In last trading session, Cabaletta Bio Inc (NASDAQ:CABA) saw 1.2 million shares changing hands with its beta currently measuring 2.31. Company’s recent per share price level of $1.91 trading at $0.12 or 6.70% at ring of the bell on the day assigns it a market valuation of $93.36M. That closing price of CABA’s stock is at a discount of -1012.04% from its 52-week high price of $21.24 and is indicating a premium of 16.75% from its 52-week low price of $1.59. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.87 million shares which gives us an average trading volume of 1.34 million if we extend that period to 3-months.
For Cabaletta Bio Inc (CABA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.44. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.64 in the current quarter.
Cabaletta Bio Inc (NASDAQ:CABA) trade information
Upright in the green during last session for gaining 6.70%, in the last five days CABA remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $1.91 price level, adding 4.98% to its value on the day. Cabaletta Bio Inc’s shares saw a change of -15.86% in year-to-date performance and have moved 3.24% in past 5-day. Cabaletta Bio Inc (NASDAQ:CABA) showed a performance of -24.51% in past 30-days. Number of shares sold short was 6.76 million shares which calculate 5.14 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 86.36% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 32. It follows that stock’s current price would drop -57.07% in reaching the projected high whereas dropping to the targeted low would mean a loss of -57.07% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -26.63% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -41.45% while estimates for its earnings growth in next 5 years are of -17.19%.
Cabaletta Bio Inc (NASDAQ:CABA)’s Major holders
Insiders are in possession of 3.10% of company’s total shares while institution are holding 79.53 percent of that, with stock having share float percentage of 82.08%. Investors also watch the number of corporate investors in a company very closely, which is 79.53% institutions for Cabaletta Bio Inc that are currently holding shares of the company. JENNISON ASSOCIATES LLC is the top institutional holder at CABA for having 5.55 million shares of worth $41.49 million. And as of 2024-06-30, it was holding 11.2498 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 4.76 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.6469 of outstanding shares, having a total worth of $35.58 million.
